Abstract:Neurodegenerative diseases (NDs) such as Alzheimer's Disease (AD) and Parkinson's Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores "digital biomarkers" (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.

Analyzing chronic disease biomarkers using electrochemical sensors and artificial neural networks

A Method for the Early Prediction of Chronic Diseases Based on Short Sequential Medical Data.

AI-Enabled Electrocardiogram Analysis for Disease Diagnosis

BIG DATA AND CHRONIC DISEASE MANAGEMENT THROUGH PATIENT MONITORING AND TREATMENT WITH DATA ANALYTICS

Real-time Predictive Health Monitoring using Ai-driven Wearable Sensors: Enhancing Early Detection and Personalized Interventions in Chronic Disease Management

Computer Based Diagnosis of Some Chronic Diseases: A Medical Journey of the Last Two Decades

Deep Neural Network Based Ensemble learning Algorithms for the healthcare system (diagnosis of chronic diseases)

An Augmented Artificial Intelligence Approach for Chronic Diseases Prediction

Multiplexed electrochemical sensing devices for chronic diseases diagnosis and monitoring

Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management

A comprehensive review for chronic disease prediction using machine learning algorithms

Advancements in Electrochemical Biosensing of Cardiovascular Disease Biomarkers

Recent advances in electrochemical biosensors for the detection of pathogens, diseases biomarkers, and heavy metal ions

ML-CKDP: Machine learning-based chronic kidney disease prediction with smart web application

Recent Advances in Electrochemical Biosensors: Applications, Challenges, and Future Scope

Bioreceptor modified electrochemical biosensors for the detection of life threating pathogenic bacteria: a review

Advances in Electrochemical Nano-Biosensors for Biomedical and Environmental Applications: From Current Work to Future Perspectives

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Machine Learning Approaches for Automated Diagnosis of Cardiovascular Diseases: A Review of Electrocardiogram Data Applications

A Comparative Study, Prediction and Development of Chronic Kidney Disease Using Machine Learning on Patients Clinical Records

Nanostructured wearable electrochemical and biosensor towards healthcare management: a review